Use of bisindolmaleimide and gemcitabine for the treatment of cancer
CA 2465807 A1 · Owner: Breimer, Lars Holger · Inventors: Ritland, Steve; Dhingra, Kapil; Dhingra, Urvashi Hooda
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of a pharmaceutical combination comprising as a active ingredients a) a component consisting of pharmaceutical composition comprising a compound of formula (I) as defined in the description and claims and b) a component consisting of pharmaceutical composition comprising as an active ingredient gemcitabine for the preparation of a medicament for the treatment of patients suffering with cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.